J. A. Davis

发表

Glycogen synthase kinase 3: more than a namesake

A. Ray, G. Rayasam, V. Tulasi, 2009, British journal of pharmacology.

Ablation of Mouse Phosphomannose Isomerase (Mpi) Causes Mannose 6-Phosphate Accumulation, Toxicity, and Embryonic Lethality*

A. Borowsky, H. Freeze, E. Eklund, 2006, Journal of Biological Chemistry.

Fatty acid receptors as new therapeutic targets for diabetes

G. Rayasam, V. Tulasi, J. A. Davis, 2007, Expert opinion on therapeutic targets.

Cryptogenic Liver Disease in Four Children: A Novel Congenital Disorder of Glycosylation

H. Freeze, P. Vajro, Y. Miura, 2006, Pediatric Research.

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.

A. Chugh, A. Ray, A. Patra, 2011, European journal of pharmacology.

Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.

J. A. Davis, K. Saini, V. Bansal, 2007, Life sciences.

Molecular cloning, gene organization, and expression of mouse Mpi encoding phosphomannose isomerase.

H. Freeze, G. Alton, J. A. Davis, 2002, Glycobiology.

Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?

C. Katiyar, S. Sujatha, J. A. Davis, 2012, Indian journal of pharmacology.

Identification of berberine as a novel agonist of fatty acid receptor GPR40

A. Ray, G. Rayasam, V. Tulasi, 2010, Phytotherapy research : PTR.

Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors.

A. Chugh, J. A. Davis, V. Bansal, 2008, Bioorganic & medicinal chemistry letters.

Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.

A. Ray, V. Tulasi, J. A. Davis, 2017, Bioorganic & medicinal chemistry letters.

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

J. A. Davis, V. Bansal, V. Khanna, 2012, Indian journal of pharmacology.

Comparative deacetylase activity of wild type and mutants of SIRT1.

Pratibha Sharma, A. Ray, J. A. Davis, 2010, Biochemical and biophysical research communications.

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes

A. Ray, J. A. Davis, C. Misra, 2011, Phytotherapy research : PTR.

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals

A. Ray, J. A. Davis, V. Bansal, 2010, Indian journal of pharmacology.

Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.

H. Freeze, S. Kjaergaard, F. Skovby, 2001, Molecular genetics and metabolism.